Nonpharmacologic methods | |
Method | Versus minimal or usual care unless otherwise noted Risk ratio (95% CI) |
Behavioral counseling | |
Individual counseling[1] | 1.57 (1.40-1.77) |
Group counseling[2] | 1.88 (1.52-2.33) |
Telephone quit line counseling[3] | 1.38 (1.19-1.61) |
Clinician counseling[4] | |
Brief advice | 1.66 (1.42-1.94) |
Brief counseling | 1.86 (1.60-2.15) |
Brief counseling (versus brief advice) | 1.37 (1.20-1.56) |
Pharmacologic methods | |
Method (number of trials) | Versus placebo unless otherwise noted Risk ratio (95% CI) |
First-line pharmacotherapies* | |
Nicotine replacement[5] | |
All types combined | 1.55 (1.49-1.61) |
Combination [versus individual products][6] | 1.25 (1.15-1.36) |
Patch (43) | 1.64 (1.53-1.75) |
Gum (56) | 1.49 (1.40-1.60) |
Lozenge (7) | 1.52 (1.32-1.74) |
Inhaler (4) | 1.90 (1.36-2.67) |
Nasal spray (4) | 2.02 (1.49-2.73) |
Varenicline[7] (27) | 2.32 (2.15-2.51) |
Bupropion SR[8] (46) | 1.60 (1.49-1.72) |
Combined pharmacologic and nonpharmacologic method | |
Method | Versus minimal or usual care unless otherwise noted Risk ratio (95% CI) |
Behavioral counseling plus pharmacotherapies[2] (52) | RR 1.83 (1.68-1.98) |
SR: sustained release.
* First-line drugs as recommended by the 2008 United States Public Health Service guideline.Do you want to add Medilib to your home screen?